Publication & Citation Trends
Publications
69 total
Vesatolimod, a toll-like receptor 7 agonist, induces immune activation in virally suppressed adults with HIV-1. OA
Cited by 57
Semantic Scholar
The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection
Cited by 0
Semantic Scholar
A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315). OA
Cited by 32
Semantic Scholar
Vesatolimod (GS-9620) is safe and pharmacodynamically active in HIV-infected individuals OA
Cited by 5
Semantic Scholar
Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption OA
Cited by 13
Semantic Scholar
Taking Control: The Efficacy and Durability of a Peer-Led Uncertainty Management Intervention for People Recently Diagnosed With HIV
Cited by 63
Semantic Scholar
Efficacy and Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in HIV-infected, Virologically Suppressed Black and Non-Blacks Adults Through Week 96: Subgroup Analysis of a Randomized Switch Study OA
Cited by 1
Semantic Scholar
Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials OA
Cited by 22
Semantic Scholar
Research Topics
HIV Research and Treatment
(37)
HIV/AIDS drug development and treatment
(34)
HIV/AIDS Research and Interventions
(29)
HIV-related health complications and treatments
(11)
Pneumocystis jirovecii pneumonia detection and treatment
(8)
Affiliations
University of North Carolina at Chapel Hill
University of Southern California
National Institutes of Health
University of California, San Francisco
Georgetown University